Par Equity led the £1.2m investment round, which also saw continued backing from Kernel Capital.
"Seldom does a day go by where the possibilities of machine learning aren’t being discussed. We’re as keenly aware as industry commentators that any successful use of this technology will rely on fast access to perfected data, something that has been our sweet spot since we were founded, and in which we’ve been investing continuously throughout my six years at the firm. We’re extremely pleased that Par Equity has come on board at this exciting time in our company’s history and look forward to working with them. Thank you for your continued support and we look forward to sharing more exciting news in the near future."
Seventure Partners led the funding round as the remittance company surpassed one million customers.
"TransferGo represents a new breed of FinTech companies that are really shaking up the remittance market. Its impressive growth and progress that really caught our attention, along with its customer-centric approach and commitment to continued innovation, make it the perfect fit for our investment strategy in the FinTech field,"
— Ludovic Denis, Venture partner in the Digital technologies team
The investment round was led by Arm, Calculus Capital, Kendall, MGL, and Guinness Asset Management.
"The strong financial foundation that our investors are giving us will be crucial to our ability to work with our partners to deliver large scale mmWave 5G deployments across a number of key markets. Working closely with our partners and their customers, we are seeing a diverse and growing range of emerging applications for our technology – whether it be for drone-to-drone communications or private enterprise networks. We’d like to thank all our shareholders for their continued support at this pivotal commercialisation phase."
Parkwalk Advisors led the financing round, which brings Congenica to a total of £23.3m raised for its Series B.
"In addition, we can now begin to penetrate international markets. The deepening of our relationship with DCHealth gives us greater insight into the needs of the China market, with the recent development of an on-premise version of our platform the most notable example."
